← All productsHORMONE
Women’s Daily Balance · 30-day system
HORMONE
BALANCESOY ISOFLAVONES AGLYCONE
A Japanese women’s wellness formula combining 30 mg of soy isoflavones in aglycone form with wild yam, pomegranate, a lactobionic-acid fermented ingredient, seaweed calcium and vitamin D.
180tablets6per dayMade in Japan
Why it was created
A thoughtful daily ritual
for changing life stages.
The formula is centred on soy isoflavones in the aglycone form, quantified at 30 mg per six-tablet daily serving.
Five complementary botanical, fermented and mineral ingredients create a broader women-focused nutrition concept for peri- and post-menopausal portfolios.
Biochemistry · receptor context
A plant-derived structure.
A context-dependent signal.
Explore why molecular structure matters when isoflavones are discussed in relation to estrogen receptors.
Explore ingredient evidenceYOTSUBA JAPAN / FORMULA STUDY
01/ 03
Aglycone form
Aglycones are isoflavone forms without the attached sugar group of their glycosides.
General biological context, not a clinical result for this supplement. Simplified and not to scale.
Formula architecture
One aglycone core.
Five complementary layers.
The women’s daily ritual
Quiet consistency,
six tablets a day.
A measured 30-day presentation turns a layered formulation into a simple daily routine. The editorial cherry-blossom setting reflects Japanese provenance without changing the product’s authentic packaging.
Six tablets dailySix formula componentsThirty-day presentation
Ingredient evidence library
Evidence, with the
right boundaries.
Important distinctionThe references below concern individual nutrients, isoflavone formats or supplemental isoflavones. They are not clinical trials of the complete Yotsuba Japan HORMONE BALANCE formula.
Soy isoflavone aglyconesIn-vitro receptor study
Receptor interaction depends on molecular form
Human estrogen-receptor binding assays found that soy isoflavone aglycones can interact differently with ERα and ERβ. This mechanistic evidence does not predict an individual response or show that the finished formula normalises hormone levels.
Isoflavone formHuman pharmacokinetic study
Aglycone and glycoside formats
A human study compared soy isoflavone aglycones with glucosides and reported differences in absorption timing and exposure. The tested preparations and doses differ from this complete Yotsuba Japan formula.
Soy isoflavonesEFSA risk assessment
Peri- and post-menopausal use
EFSA reviewed supplemental isoflavone safety for peri- and post-menopausal women. This is a risk assessment, not proof that the finished product treats menopausal symptoms.
Calcium + vitamin DNIH nutrient reference
A complementary nutrient pairing
NIH explains that calcium is a structural component of bones and teeth and that vitamin D is required for active intestinal calcium absorption. The product label does not state an elemental calcium amount.
Professional product data
Complete details,
clearly organised.
Professionals can review the complete Japanese ingredient declaration, allergens, format, nutrition, directions and handling information below.Complete ingredients & allergens01
Current Japanese composition: Seaweed calcium (manufactured in the United Kingdom), wild yam extract, lactose-fermented product containing lactobionic acid, pomegranate fruit extract powder, maltitol, soy isoflavone extract containing aglycones, crystalline cellulose, silicon dioxide, calcium stearate and vitamin D.
Allergen information: Contains milk and soybean. The approved destination-market label remains authoritative.
Format & daily serving02
Format 180 tabletsDaily serving 6 tabletsSupply 30 daysNet content 63.0 gTablet weight 350 mgDaily serving weight 2.1 g
Nutrition per daily serving03
Energy 6.13 kcalProtein 0.01 gFat 0.07 gCarbohydrate 1.37 gSalt equivalent 0.008 gSoy isoflavones aglycone 30 mg
Values are stated on the current Japanese package per six-tablet daily serving (2.1 g). No individual quantities are declared for the other ingredients.
Use, storage & precautions04
Take six tablets daily with water or warm water. Store away from high temperature, humidity and direct sunlight. If the product does not agree with your constitution, reduce the amount or discontinue use. People taking medicines or receiving medical care should consult a physician before use. Consume promptly after opening. Natural variations in colour may occur without affecting quality. This is a health food product, not a medicine.
日本GMP
PRODUCTION
PRODUCTION
Japanese quality & provenance
Developed as a complete
30-day women’s system.
The 180-tablet presentation is produced in Japan under the GMP manufacturing standards declared on the current product packaging.
Frequently asked
Clear answers,
without overclaiming.
01What is “aglycone”?+
In soy, isoflavones can occur attached to a sugar group as glycosides. Aglycone describes the corresponding sugar-free molecular form. The animation on this page is conceptual and is not a simulation of absorption.
02What is the daily serving?+
The current Japanese directions indicate six tablets per day with water or warm water. Follow the approved destination-market label.
03What amount is declared on the Japanese package?+
The current Japanese package declares 30 mg of soy isoflavones aglycone per daily serving of six tablets. It does not state individual quantities for the other ingredients.
04What allergens are declared?+
The current Japanese ingredient declaration identifies milk and soybean. The approved market-specific label remains authoritative.
05Who should seek professional advice?+
Anyone who is pregnant or breastfeeding, receives medical care, takes medication, or has a hormone-sensitive medical history should consult an appropriate healthcare professional before use.
Food supplement · Not a medicine
Product information is educational and intended for professional portfolio review. It is not medical advice and is not intended to diagnose, treat, cure or prevent disease. Suitability, permitted claims and labelling must be assessed for each destination market.HORMONE BALANCE · Women’s Daily Balance